Alacris Theranostics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $955K

  • Investors
  • 1

Alacris Theranostics General Information

Description

Operator of a biotech company intended to develop precision immuno-oncology treatments. The company is engaged in developing cancer immunotherapies to fight multiple cancer types using Comprehensive Molecular Tumor Analysis, enabling researchers to focus on the advancement of novel drugs in areas of unmet medical needs.

Contact Information

Website
www.alacris.de
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Max-Planck-Straße 3
  • 12489 Berlin
  • Germany
+49 030 00000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alacris Theranostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Equity Crowdfunding 11-Sep-2020 $955K 00000 Completed Generating Revenue
1. Corporate 11-Jan-2011 Completed Generating Revenue
To view Alacris Theranostics’s complete valuation and funding history, request access »

Alacris Theranostics Patents

Alacris Theranostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3296905-A1 Method for identifying new markers Active 15-Sep-2016 000000000
EP-3296905-B1 Method for identifying new markers Active 15-Sep-2016 000000000
EP-3296905-C0 Method for identifying new markers Active 15-Sep-2016 000000000
EP-3083984-A1 Method for generating of oligonucleotide arrays using in situ block synthesis approach Inactive 16-Dec-2013 0000000000
US-20160355878-A1 Method for generating of oligonucleotide arrays using in situ block synthesis approach Inactive 16-Dec-2013 C12Q1/6837 0
To view Alacris Theranostics’s complete patent history, request access »

Alacris Theranostics Executive Team (6)

Name Title Board Seat Contact Info
Bodo Lange Chief Executive Officer
Marie-Laure Yaspo Ph.D Co-Founder & Chief Scientific Officer
George Church Ph.D Co-Founder & Advisor
Hans Lehrach Ph.D Co-Founder & Chairman
You’re viewing 4 of 6 executive team members. Get the full list »

Alacris Theranostics Board Members (3)

Name Representing Role Since
Hans Lehrach Ph.D Alacris Theranostics Co-Founder & Chairman 000 0000
Michael Tysiak Self Board Member 000 0000
Sebastian Meier-Ewert Ph.D Self Board Member 000 0000
To view Alacris Theranostics’s complete board members history, request access »

Alacris Theranostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alacris Theranostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Qiagen Corporation Minority 000 0000 000000 0
To view Alacris Theranostics’s complete investors history, request access »

Alacris Theranostics FAQs

  • When was Alacris Theranostics founded?

    Alacris Theranostics was founded in 2011.

  • Who is the founder of Alacris Theranostics?

    Marie-Laure Yaspo Ph.D, George Church Ph.D, and Hans Lehrach Ph.D are the founders of Alacris Theranostics.

  • Who is the CEO of Alacris Theranostics?

    Bodo Lange is the CEO of Alacris Theranostics.

  • Where is Alacris Theranostics headquartered?

    Alacris Theranostics is headquartered in Berlin, Germany.

  • What is the size of Alacris Theranostics?

    Alacris Theranostics has 13 total employees.

  • What industry is Alacris Theranostics in?

    Alacris Theranostics’s primary industry is Drug Discovery.

  • Is Alacris Theranostics a private or public company?

    Alacris Theranostics is a Private company.

  • What is Alacris Theranostics’s current revenue?

    The current revenue for Alacris Theranostics is 000000.

  • How much funding has Alacris Theranostics raised over time?

    Alacris Theranostics has raised $955K.

  • Who are Alacris Theranostics’s investors?

    Qiagen has invested in Alacris Theranostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »